| 今开：1.74 | 昨收：1.71 |
| 最高：1.78 | 最低：1.71 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.3268613E7 |
Rafael Holdings(RFL)2023-01-31 00:21
$Rafael Holdings(RFL)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-23-005396 Size: 6 KB 网页链接查看全文
Rafael Holdings(RFL)2023-01-27 05:36
$Rafael Holdings(RFL)$ 8-K Current report, item 5.07 Accession Number: 0001213900-23-005346 Act: 34 Size: 229 KB 网页链接查看全文
chuminhua2021-10-29 10:29
10月28日，在宣布Rafael Pharmaceuticals$Rafael Holdings(RFL)$ 的devimistat在一线胰腺癌患者中的III期研究未能达到总生存期（OS）的主要终点后，Rafael Holdings的股票在周四暴跌了80%。此外，该实验性抗线粒体药物在复发或难治性急性骨髓性白血病（AML）患者中的后期试验也因缺乏疗效而被停止...查看全文
Rafael Holdings(RFL)2023-01-06 03:36
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-001686 Size: 4 KB 网页链接查看全文
Rafael Holdings(RFL)2023-01-06 03:36
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-001689 Size: 4 KB 网页链接查看全文
Rafael Holdings(RFL)2023-01-06 03:42
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-001695 Size: 4 KB 网页链接查看全文
Rafael Holdings(RFL)2023-01-06 03:42
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-001692 Size: 4 KB 网页链接查看全文
Rafael Holdings(RFL)2023-01-06 05:57
$Rafael Holdings(RFL)$ 8-K Current report, item 5.02 Accession Number: 0001213900-23-001143 Act: 34 Size: 214 KB 网页链接查看全文
Rafael Holdings(RFL)2022-12-23 23:12
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-062551 Size: 4 KB 网页链接查看全文
chuminhua2021-10-29 10:29
10月28日，在宣布Rafael Pharmaceuticals$Rafael Holdings(RFL)$ 的devimistat在一线胰腺癌患者中的III期研究未能达到总生存期（OS）的主要终点后，Rafael Holdings的股票在周四暴跌了80%。此外，该实验性抗线粒体药物在复发或难治性急性骨髓性白血病（AML）患者中的后期试验也因缺乏疗效而被停止...查看全文
chuminhua2020-11-22 11:09
11/16，美国食品和药物管理局（FDA）授予Rafael制药$Rafael Holdings(RFL)$ 公司的CPI-613，即devimistat，治疗胰腺癌的快速通道地位。Devimistat还获得了治疗骨髓增生异常综合征、急性髓系白血病、伯基特淋巴瘤、外周T细胞淋巴瘤和软组织肉瘤的孤儿药标签。$rafael查看全文
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042512 Size: 9 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035670 Size: 4 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-035671 Size: 5 KB 网页链接
$Rafael Holdings(RFL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-022343 Act: 34 Size: 9 MB 网页链接
$Rafael Holdings(RFL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-022271 Act: 34 Size: 309 KB 网页链接
$Rafael Holdings(RFL)$ 8-K Current report, items 2.01 and 9.01 Accession Number: 0001213900-24-022185 Act: 34 Size: 204 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009772 Size: 11 KB 网页链接
$Rafael Holdings(RFL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-005202 Size: 5 KB 网页链接
$Rafael Holdings(RFL)$ 8-K Current report, item 5.07 Accession Number: 0001213900-24-003527 Act: 34 Size: 223 KB 网页链接
$Rafael Holdings(RFL)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-004205 Size: 3 KB 网页链接